Project Grant HT9425261E419
Award Date 8/31/26
Completion Date 7/31/29
Dollars Obligated $1.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Irwindale, CA 91010, USA
Similar Awards
- Federal Grant Award Summary Beckman Research Institute of the City of Hope received a $2.136 million Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2028. The award supports developmental therapeutics research and the investigation of potential treatment strategies targeting RALBP1 (Retinoid-binding Protein 1) for castration-resistant prostate carcinoma. This...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded $177,992 to Beckman Research Institute of The City of Hope under the Military Medical Research and Development program (CFDA 12.420) for the project "Generation of Novel Tools for the Development of Targeted Approaches for AL Amyloidosis." The two-year award period runs from September 1, 2025, through August 31, 2027, with research conducted at the Institute's Irwindale, California facility. This project supports DHA's...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Beckman Research Institute of The City of Hope a $416,217 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period September 30, 2026 through September 29, 2029. The award supports research on photoacoustic computed tomography (PACT) to identify and diagnose axillary lymph nodes in breast cancer patients without requiring surgical intervention. This diagnostic imaging research...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $140,000 under the Military Medical Research and Development program (CFDA 12.420) to the Beckman Research Institute of the City of Hope, effective September 1, 2026 through August 31, 2027. This one-year project grant funds research on "Enhancing TIL Trafficking via Paired Cell Engineering and Lipid Nanoparticle Modulation of the Tumor Microenvironment in Mucosal Melanoma," with research activities conducted...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $1.1M to the Beckman Research Institute of the City of Hope under the Military Medical Research and Development program (CFDA 12.420) to develop LRRC15-targeted Chimeric Antigen Receptor (CAR) T cell therapy for osteosarcoma. The three-year project, initiated June 1, 2026 and concluding May 31, 2029, will be conducted at the Institute's Irwindale, California research facility. This award represents DHA's commitment to...
- Federal Project Grant Award Summary The Beckman Research Institute of the City of Hope received a $1.32M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 15, 2025, with completion targeted for September 14, 2029. The award supports research titled "Targeting Diabetes-Associated Radioresistance to Improve Prostate Cancer Control and Quality-of-Life Outcomes," conducted at the...
- Federal Grant Award Summary Dana-Farber Cancer Institute, Inc. received a $1.12M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2026, through August 31, 2030. The award supports resource development activities aimed at improving clinical and research outcomes for blastic plasmacytoid dendritic cell neoplasm, a rare hematologic malignancy. The project deliverables will advance knowledge and...
- This $615,999 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Beckman Research Institute of the City of Hope, a nonprofit organization. The grant funds research to develop a "Targeted Telomere-Disrupting Oligonucleotide for Acute Myeloid Leukemia Therapy" over a 3-year period from Sep 1, 2023 to Aug 31, 2026. As a nonprofit research organization, Beckman Research Institute leverages its medical...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...
- Federal Project Grant Award Summary Emory University's Office of Sponsored Programs received a $1.62M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026, through August 31, 2029. The award funds investigator-initiated research on chemotherapy induction regimens for lineage switch acute myeloid leukemia (LS-AML) or mixed phenotype acute leukemia (LS-MPAL) occurring post-ALL (acute lymphoblastic...